<DOC>
	<DOCNO>NCT00379249</DOCNO>
	<brief_summary>The primary objective study compare effect rosuvastatin therapy plus compliance initiative rosuvastatin therapy alone 12 month ( 52 week ) long-term cumulative direct indirect disease-related cost 36 month .</brief_summary>
	<brief_title>Rosuvastatin ORBITAL Germany</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>high cholesterol indication cholesterollowering medication ( statin ) contraindication statin therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>statin</keyword>
	<keyword>compliance</keyword>
</DOC>